Antabuse: Clinically Proven Alcohol Dependence Treatment

Antabuse

Antabuse

Price from 39.56 $
Product dosage: 250mg
Package (num)Per pillPriceBuy
90$0.44$39.56 (0%)🛒 Add to cart
120$0.41$52.75 $49.02 (7%)🛒 Add to cart
180$0.39$79.12 $70.52 (11%)🛒 Add to cart
270$0.38$118.68 $101.48 (14%)🛒 Add to cart
360
$0.37 Best per pill
$158.24 $131.58 (17%)🛒 Add to cart
Product dosage: 500mg
Package (num)Per pillPriceBuy
60$0.82$49.02 (0%)🛒 Add to cart
90$0.73$73.53 $65.36 (11%)🛒 Add to cart
120$0.67$98.04 $80.84 (18%)🛒 Add to cart
180$0.62$147.06 $111.80 (24%)🛒 Add to cart
270$0.59$220.59 $159.10 (28%)🛒 Add to cart
360
$0.58 Best per pill
$294.12 $208.12 (29%)🛒 Add to cart
Synonyms

Antabuse (disulfiram) is a prescription medication designed to support the treatment of chronic alcoholism by creating an aversive physiological response to alcohol consumption. It functions as a deterrent therapy, discouraging alcohol intake through the induction of unpleasant effects when ethanol is ingested. This medication is intended for use as part of a comprehensive treatment plan that includes counseling and psychosocial support. Administered under medical supervision, Antabuse aids in maintaining abstinence and promoting long-term recovery in motivated patients.

Features

  • Active ingredient: Disulfiram 250 mg or 500 mg tablets
  • Mechanism of action: Inhibits aldehyde dehydrogenase, leading to acetaldehyde accumulation
  • Administration: Oral tablet, once daily
  • Onset of action: Effects begin within 1-2 hours after ingestion
  • Duration of effect: May persist for up to 14 days after discontinuation
  • Prescription status: Schedule IV controlled substance
  • Manufacturer: Various pharmaceutical companies under FDA approval

Benefits

  • Creates a powerful psychological deterrent against alcohol consumption
  • Supports long-term abstinence when combined with behavioral therapy
  • Provides a tangible treatment framework for recovery maintenance
  • Reduces alcohol craving through negative reinforcement
  • Enhances patient accountability in treatment programs
  • Facilitates development of new coping mechanisms during sobriety

Common use

Antabuse is primarily prescribed for the management of chronic alcohol dependence in patients who want to remain in a state of enforced sobriety. It is most effective when used as part of a comprehensive treatment program that includes medical supervision, counseling, and social support. The medication is typically initiated after the patient has undergone alcohol detoxification and has been alcohol-free for at least 12 hours. Treatment is generally recommended for patients who are motivated to maintain abstinence and who understand the consequences of alcohol consumption while taking the medication.

Dosage and direction

The initial recommended dosage is 500 mg daily for 1-2 weeks, typically administered as a single dose in the morning. Maintenance dosage ranges from 125 mg to 500 mg daily based on individual tolerance and response. The tablet should be swallowed whole with water, preferably at the same time each day. Treatment should not be initiated until the patient has abstained from alcohol for at least 12 hours. Dosage adjustments should be made under medical supervision, and treatment duration is individualized based on patient progress and treatment goals.

Precautions

Patients must be fully informed about the Antabuse-alcohol reaction and must avoid all alcohol-containing products, including medications, foods, and toiletries. Regular liver function tests are recommended during treatment due to potential hepatotoxicity. Use with caution in patients with diabetes mellitus, hypothyroidism, epilepsy, cerebral damage, chronic or acute nephritis, hepatic cirrhosis, or hepatic insufficiency. Patients should carry medical identification indicating they are taking disulfiram. Psychiatric status should be monitored regularly, as depression and psychotic episodes have been reported.

Contraindications

Antabuse is contraindicated in patients with severe myocardial disease or coronary occlusion, psychoses, hypersensitivity to disulfiram or other thiuram derivatives, and those who have recently metronidazole, paraldehyde, alcohol, or alcohol-containing preparations. It should not be administered to patients without their full knowledge or to those who are likely to drink alcohol despite the warning. Contraindicated in pregnancy unless the potential benefit justifies the potential risk to the fetus.

Possible side effects

Common side effects include drowsiness, fatigue, impotence, headache, acneiform eruptions, allergic dermatitis, and metallic or garlic-like aftertaste. Less frequently reported effects include hepatotoxicity, peripheral neuropathy, optic neuritis, polyneuritis, and psychiatric symptoms including depression, psychosis, and confusion. The most significant adverse effect is the disulfiram-ethanol reaction, characterized by flushing, throbbing headache, respiratory difficulty, nausea, copious vomiting, sweating, thirst, chest pain, palpitations, dyspnea, hyperventilation, tachycardia, hypotension, syncope, marked uneasiness, weakness, vertigo, blurred vision, and confusion.

Drug interaction

Antabuse inhibits several hepatic enzyme systems, potentially affecting the metabolism of numerous medications. Significant interactions occur with: warfarin (increased anticoagulant effect), phenytoin (increased serum levels), benzodiazepines (prolonged effects), theophylline (increased serum levels), tricyclic antidepressants (increased levels), and metronidazole (increased risk of psychotic reactions). Concurrent use with alcohol-containing preparations (including cough syrups, tonics, and vinegar) precipitates the disulfiram-ethanol reaction. Avoid concomitant administration with paraldehyde.

Missed dose

If a dose is missed, it should be taken as soon as remembered unless it is almost time for the next dose. Do not double the dose to make up for a missed one. The protective effect against alcohol diminishes if doses are missed regularly. Patients should maintain regular dosing schedule and contact their healthcare provider if multiple doses are missed to discuss treatment continuation.

Overdose

Symptoms of overdose may include nausea, vomiting, dizziness, ataxia, seizures, coma, and respiratory depression. In severe cases, cardiovascular collapse and death may occur. Management includes gastric lavage if presented early, supportive care, and symptomatic treatment. There is no specific antidote. Hemodialysis may be considered in severe cases. Patients should be monitored for hepatic and neurological complications for several days following overdose.

Storage

Store at controlled room temperature (20°-25°C or 68°-77°F) in a tight, light-resistant container. Keep out of reach of children and pets. Do not store in bathroom or near kitchen sink where moisture could affect stability. Discard any unused medication after the expiration date printed on the packaging. Do not flush medications down the toilet or pour into drain unless instructed to do so.

Disclaimer

This information is for educational purposes only and does not constitute medical advice. Antabuse is a prescription medication that should only be used under the supervision of a qualified healthcare professional. Individual results may vary, and the medication may not be suitable for all patients. Always follow your healthcare provider’s instructions regarding dosage, administration, and treatment duration. Report any adverse effects to your healthcare provider immediately.

Reviews

Clinical studies demonstrate that Antabuse, when combined with comprehensive treatment programs, significantly improves abstinence rates compared to placebo. Patient reviews indicate varied experiences, with many reporting successful long-term sobriety when used as directed, while others note challenging side effects. Success appears highest in motivated patients with strong support systems. Medical professionals emphasize that Antabuse is most effective as part of a multifaceted approach to alcohol dependence treatment rather than as a standalone solution.